F.D.A. Faces Upset Over Denials of New Drugs

Source: NYT > U.S. > Politics · Bias: Center Left

Summary

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.

Related Coverage

More Headlines From March 5, 2026

F.D.A. Faces Upset Over Denials of New Drugs
NYT > U.S. > Politics

F.D.A. Faces Upset Over Denials of New Drugs

Center Left

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.